rtki cpd has been researched along with Insulin Resistance in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Benterki, I; Fontés, G; Peyot, ML; Poitout, V; Prentki, M; Seda, O; Zarrouki, B | 1 |
Arellano-Plancarte, A; Catt, KJ; Hernandez-Aranda, J; Olivares-Reyes, JA | 1 |
2 other study(ies) available for rtki cpd and Insulin Resistance
Article | Year |
---|---|
Epidermal growth factor receptor signaling promotes pancreatic β-cell proliferation in response to nutrient excess in rats through mTOR and FOXM1.
Topics: Animals; Cell Cycle; Cell Proliferation; Cells, Cultured; ErbB Receptors; Forkhead Box Protein M1; Forkhead Transcription Factors; Gene Expression Profiling; Insulin Resistance; Insulin-Secreting Cells; Male; Quinazolines; Rats; Rats, Wistar; Signal Transduction; TOR Serine-Threonine Kinases; Tyrphostins | 2014 |
Angiotensin-induced EGF receptor transactivation inhibits insulin signaling in C9 hepatic cells.
Topics: Angiotensin II; Animals; Cell Line; Enzyme Inhibitors; ErbB Receptors; Hepatocytes; Insulin; Insulin Resistance; Phosphorylation; Proto-Oncogene Proteins c-akt; Quinazolines; Rats; Receptor, Insulin; Serine; Signal Transduction; Threonine; Transcriptional Activation; Tyrphostins; Vasoconstrictor Agents | 2010 |